Rashmi K. Murthy, MD

Articles by Rashmi K. Murthy, MD

Tucatinib Combination Improved Survival in HER2+ Breast Cancer

January 30th 2020

Rashmi K. Murthy, MD, discusses the pivotal HER2CLIMB trial, which evaluated the addition of tucatinib to trastuzumab plus capecitabine in patients with HER2-positive metastatic breast cancer.

Latest Updated Articles

Tucatinib Combination Improved Survival in HER2+ Breast Cancer
Published: January 30th 2020 | Updated: